Axsome Therapeutics, Inc. SEC filings AXSM
Axsome Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Jun 19, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Nov 3, 2025 | — |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| S-8 | Employee stock plan registration | Aug 5, 2024 | — |
| 424B5 | Prospectus supplement | Jun 29, 2023 | — |
| 424B5 | Prospectus supplement | Jun 28, 2023 | — |
| S-8 | Employee stock plan registration | Jun 23, 2023 | — |
| S-8 | Employee stock plan registration | May 9, 2023 | — |
| S-3ASR | Automatic shelf registration | Dec 2, 2022 | — |
| 424B5 | Prospectus supplement | Aug 22, 2022 | — |
| S-8 | Employee stock plan registration | May 2, 2022 | — |
| 424B5 | Prospectus supplement | Mar 1, 2022 | — |
| S-8 | Employee stock plan registration | May 11, 2021 | — |
| S-8 | Employee stock plan registration | May 11, 2020 | — |
| 424B5 | Prospectus supplement | Dec 20, 2019 | — |
| 424B5 | Prospectus supplement | Dec 18, 2019 | — |
| S-3ASR | Automatic shelf registration | Dec 5, 2019 | — |
| 424B5 | Prospectus supplement | May 9, 2019 | — |
| S-8 | Employee stock plan registration | Mar 15, 2019 | — |
| 424B5 | Prospectus supplement | Sep 28, 2018 | — |
| S-8 | Employee stock plan registration | Aug 13, 2018 | — |
| 424B5 | Prospectus supplement | Dec 4, 2017 | — |
| 424B5 | Prospectus supplement | Oct 20, 2017 | — |
| S-8 | Employee stock plan registration | Mar 29, 2017 | — |
| 424B5 | Prospectus supplement | Mar 21, 2017 | — |
| 424B5 | Prospectus supplement | Mar 20, 2017 | — |
| S-3 | Shelf registration | Dec 1, 2016 | — |
| S-8 | Employee stock plan registration | Dec 16, 2015 | — |
| 424B4 | Prospectus | Nov 19, 2015 | — |
| S-1/A | Amended registration statement | Nov 2, 2015 | — |
| S-1 | Registration statement | Oct 13, 2015 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1579428
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.